Bullboard Post History

by qwerty22

Order by:

T.TH	RE:RE:RE:RE:RE:RE:RE:What did we learn here? I noticed at the bottom of the page there's article metrics showing daily... September 12, 2022
T.TH	RE:RE:RE:RE:RE:RE:What did we learn here? I was going to tell you the turnaround on science publishing was too long for... September 12, 2022
T.TH	RE:RE:What did we learn here? Agreed that's definitely the long term story, short term it's patient... September 12, 2022
T.TH	RE:RE:RE:RE:RE:Targeting Cancer Stem Cells Lol, I'm never knowingly correct! TH1902 wrote: AND WE ARE MOVING UP,... September 12, 2022
V.FL	Will we get another drill report this week? Eom September 12, 2022
T.TH	RE:RE:What did we learn here? Yeah good point, maybe they can share this with the docs at the sites. I... September 12, 2022
T.TH	RE:Car-T TCell competition - Adaptimmune ESMO One company getting a lot of attention at EMSO seems to be Relay therapeutics... September 12, 2022
V.RHT.H	RE:RE:RE:Revenue Recognition Cheers, I'd agree 75% would be great and I mostly believe they are taking... September 11, 2022
V.RHT.H	RE:Revenue Recognition So theinvestor22, let's say 75% of patients become compliant (just a... September 10, 2022
V.RHT.H	RE:RE:RE:Revenue Recognition https://mhealth.jmir.org/2019/2/e13259 RPM for heart failure patients... September 10, 2022
V.RHT.H	RE:RE:Revenue Recognition https://www.aha.org/aha-center-health-innovation-market-scan/2021-09-14... September 10, 2022
V.RHT.H	RE:Revenue Recognition Has becoming "compliant" been explained anywhere in detail? If a... September 10, 2022
V.RHT.H	RE:RE:RE:Market is saying: I DON'T BELIEVE YOU Clearly you're getting emotional which might be why there's no logic... September 9, 2022
T.TH	Paris NASH 2022 is happening now Oddly Thera is one of the sponsors. So seems they are still trying to... September 9, 2022
V.RHT.H	RE:Market is saying: I DON'T BELIEVE YOU No evidence the market doesn't believe they are real. More likely the... September 9, 2022
T.TH	RE:RE:RE:RE:Down again I don't disagree with this but it hasn't happened (yet... September 9, 2022
T.TH	RE:RE:RE:Down again I remember one time being told quietly by my CFO that I just couldn't... September 9, 2022
T.TH	RE:RE:Targeting Cancer Stem Cells It reads really well, like all their pre-clinical work. The obvious question... September 9, 2022
T.TH	RE:Targeting Cancer Stem Cells Seemed familiar. Looks like it's a full paper version of the poster they... September 9, 2022
V.FL	RE:qwerty....Buy High and then Buy Higher It's just one week it's a slumbering giant going nowhere and the next... September 9, 2022

Become a member today, It's free!

Bullboard Post History

by qwerty22

RE:RE:RE:RE:RE:RE:RE:What did we learn here?

RE:RE:RE:RE:RE:RE:What did we learn here?

RE:RE:What did we learn here?

RE:RE:RE:RE:RE:Targeting Cancer Stem Cells

Will we get another drill report this week?

RE:RE:What did we learn here?

RE:Car-T TCell competition - Adaptimmune ESMO

RE:RE:RE:Revenue Recognition

RE:Revenue Recognition

RE:RE:RE:Revenue Recognition

RE:RE:Revenue Recognition

RE:Revenue Recognition

RE:RE:RE:Market is saying: I DON'T BELIEVE YOU

Paris NASH 2022 is happening now

RE:Market is saying: I DON'T BELIEVE YOU

RE:RE:RE:RE:Down again

RE:RE:RE:Down again

RE:RE:Targeting Cancer Stem Cells

RE:Targeting Cancer Stem Cells

RE:qwerty....Buy High and then Buy Higher

Featured Company

Kootenay Silver Inc. V.KTN

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by qwerty22

Featured Company